author-photo

Shinichiro Okamoto

Keio University

719

Papers

11122

Citations

Citation Trend

Filter By

Papers (524) Sort By

Journal Conference Others

Erratum: Human herpesvirus 6 reactivation evaluated by digital polymerase chain reaction and its association with dynamics of CD134-Positive T cells after allogeneic hematopoietic stem cell transplantation (Journal Infectious Diseases (2019) 220:6 (1001-1007) DOI: 10.1093/infdis/jiz237)

2021 The Journal of Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
International Blood and Marrow Registries: trends on long‐term data collection

2021
Show All
- Source
- Cite
- Save
Citations (0)
Impact of chronic GVHD on QOL assessed by visual analogue scale in pediatric HSCT survivors and differences between raters: a cross-sectional observational study in Japan

2021 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1 study of plerixafor in combination with total body irradiation-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation.

2021 International Journal of Hematology
Show All
- Source
- Cite
- Save
Citations (0)
Predictors for Improvement in Patient-Reported Outcomes: Post-Hoc Analysis of a Phase 3 Randomized, Open-Label Study of Eculizumab and Ravulizumab in Complement Inhibitor-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Reverting to Quiescence Preserves Hematopoietic Stem Cells Following Genome Editing

2021 Blood
Show All
- Source
- Cite
- Save
Citations (0)
Successful ibrutinib treatment for central nervous system relapse of chronic lymphocytic leukemia after allogeneic hematopoietic stem cell transplantation

2021 Annals of Hematology
Show All
- Source
- Cite
- Save
Citations (0)
OGT Regulates Hematopoietic Stem Cell Maintenance via PINK1-Dependent Mitophagy

2021 Cell Reports
Show All
- Source
- Cite
- Save
Citations (4)
One-year efficacy and safety of ravulizumab in adults with paroxysmal nocturnal hemoglobinuria naïve to complement inhibitor therapy: open-label extension of a randomized study

2020 Therapeutic advances in hematology
Show All
- Source
- Cite
- Save
Citations (1)
Efficacy and Safety of Concomitant Use of Ravulizumab and IST in Patients with Paroxysmal Nocturnal Hemoglobinuria up to 52 Weeks

2020 Blood
Show All
- Source
- Cite
- Save
Citations (0)